Clinical Trial Update: Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating aerosolized recombinant alpha-1 antitrypsin in subjects with alpha-1 antitrypsin deficiency has completed Phase 1/2 studies measurin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• Aerosolized, recombinant Alpha 1-Antitrypsin (alpha-1 antitrypsin)

Snippet

Sponsor: Baxalta now part of Shire | Conditions: Alpha1-antitrypsin Deficiency | Phase 1, Phase 2 | Status: COMPLETED